Advanced Medical Solutions — Shareholder Meeting (June 2022)

4 slides from Advanced Medical Solutions's shareholder meeting presentation, Jun 8, 2022

Slide 1: Advanced Medical Solutions AGM Presentation – 8th June 2022
Advanced Medical Solutions AGM Presentation – 8th June 2022 Unless stated otherwise, the contents of this presentation have been extracted from the preliminary results presentation of 16 March 2022 11
Slide 2: Financial Highlights
Financial Highlights Strong recovery in 2021 as product demand returns towards pre-pandemic levels • AMS’ core businesses continued to recover as elective surgery and woundcare treatment volumes return towards pre-pandemic levels driving 29%* increase in Group revenues • Higher volumes and increased
Slide 3: Operational Highlights
Operational Highlights Regulatory and clinical progress as investment continues in next-generation products • LiquiBand® XL 510(k) approval received (May 2022). US launch planned for Q3 2022 • SEAL-G® and SEAL-G® MIST clinical study continues to progress well. Clinical results on track to be release
Slide 4: Summary and Outlook
Summary and Outlook Positioned for further growth with a promising pipeline of next-generation products • AMS’ core businesses recovered strongly in 2021 as markets recovered from the impact of COVID-19 • Good progress has been made in expanding our geographic footprint with new distributors appoint